Ben Kridis et al reported a Milano Policlinico ONCOVID modified score for evaluating a cancer patient with COVID-19. The authors are from Habib Bourguiba Hospital University of Sfax in Tunisia.
Patient selection: cancer patient with COVID-19
Parameters:
(1) sex of the patient
(2) ECOG performance status
(3) age in years
(4) body mass index (BMI)
(5) number of comorbidities
(6) concomitant steroid therapy
(7) thoracic tumor
(8) history of thoracic radiotherapy
(9) adjuvant chemotherapy
(10) type of treatment
(11) history of immune-related adverse events (IRAE)
(12) neutrophil-to-lymphocyte ratio
Parameter |
Finding |
Points |
sex |
female |
0 |
|
male |
1 |
ECOG |
0 or 1 |
0 |
|
2 to 4 |
1 |
age |
< 70 years |
0 |
|
>= 70 years |
1 |
BMI |
< 30 kg per sq m |
0 |
|
>= 30 kg per sq m |
1 |
comorbidities |
0 |
0 |
|
1 |
1 |
|
>= 2 |
2 |
steroid therapy |
no |
0 |
|
yes |
1 |
thoracic tumor |
no |
0 |
|
yes |
1 |
thoracic radiotherapy |
no |
0 |
|
yes |
1 |
adjuvant chemotherapy |
no |
0 |
|
yes |
1 |
type of treatment |
chemotherapy |
1 |
|
chemotherapy and immunotherapy |
2 |
|
immunotherapy |
2 |
|
other |
0 |
history of IRAE |
no |
0 |
|
pneumonitis |
2 |
|
other immune |
1 |
NLR |
< 5 |
0 |
|
>= 5 |
1 |
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: 0
• maximum score: 15
Total Score |
Risk Category |
0 to 3 |
low |
4 to 6 |
intermediate |
7 to 15 |
high |
Specialty: Infectious Diseases